Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 15, 2026
IFNα2b modulates anti-tumor immune responses involving STAT3-associated dendritic cell dysfunction in JAK2v617f-positive myeloproliferative neoplasmsLijun Fang, Rongfeng Fu, Huan Dong, et al.
The Journal of Allergy and Clinical Immunology|February 3, 2026
Club Cell RhoA Activation Amplifies Allergic Airway Inflammation by Regulating Epithelial Integrity and C1qα+ Interstitial MacrophagesWei Tu, Maolan Wu, Rongjun Wan, et al.
British Journal of Haematology|January 28, 2023
Molecular analysis of phenotypic heterogeneity in JAK2V617F-positive myeloproliferative neoplasms reveals a potential target for therapyWenjing Gu, Jingyuan Tong, Rongfeng Fu, et al.
Haematologica|July 11, 2019
Multilevel defects in the hematopoietic niche in essential thrombocythemiaTing Sun, Mankai Ju, Xinyue Dai, et al.
British Journal of Haematology|July 1, 2026
Clinical heterogeneity in congenital factor XII deficiency: Coexisting risk factors in thrombotic and bleeding eventsXinmiao Qu, Yujiao Jia, Yuhua Wang, et al.
Clinical and Experimental Medicine|July 7, 2024
Multi-omics differences in the bone marrow between essential thrombocythemia and prefibrotic primary myelofibrosisAnqi Zhang, Ting Sun, Dandan Yu, et al.
Eclinicalmedicine|April 6, 2026
Daratumumab in patients with immune thrombocytopenia: a single-center, open-label, phase 2 trialYunfei Chen, Zhengjie Hua, Yanmei Xu, et al.
Leukemia|October 7, 2024
Childhood and adolescent essential thrombocythemia and prefibrotic primary myelofibrosis: insights into diagnosis, outcomes, and treatment from a large Chinese cohortRongfeng Fu, Huan Dong, Wenjing Gu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2024
Reduced Platelet Activation in Triple-Negative Essential Thrombocythemia Compared with JAK2V617F-Mutated Essential ThrombocythemiaHuan Dong, Jia Chen, Jing Zhang, et al.
The New England Journal of Medicine|June 20, 2024
A Novel Anti-CD38 Monoclonal Antibody for Treating Immune ThrombocytopeniaYunfei Chen, Yanmei Xu, Huiyuan Li, et al.
Pageof 9